LIFECORE BIOMEDICAL INC (LFCR) Stock Analyst Earnings Estimates
NASDAQ:LFCR - Nasdaq - US5147661046 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 185.8M 8.34% | 103.269M -44.42% | 128.261M 24.20% | 131.13M 2.24% | 141.46M 7.88% | 157.7M 11.48% | 181.51M 15.10% | |
| EBITDA YoY % growth | 14.38M -43.09% | -6.435M -144.75% | 1.671M 125.97% | 19.779M 1,083.66% | 23.47M 18.66% | 30.926M 31.77% | N/A | |
| EBIT YoY % growth | -3.5M -164.81% | -19.72M -463.43% | -7.188M 63.55% | -10.759M -49.67% | -4.088M 62.00% | 2.154M 152.69% | N/A | |
| Operating Margin | -1.88% | -19.10% | -5.60% | -8.20% | -2.89% | 1.37% | N/A | |
| EPS YoY % growth | -0.27 -145.45% | -1.67 -518.52% | N/A 125.04% | -0.86 -304.88% | -0.61 28.57% | -0.43 29.17% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -125.00% | -0.04 79.00% | -0.31 37.55% | -0.15 40.84% | -0.10 25.93% | -0.06 -57.14% | -0.34 -10.00% | -0.22 -51.72% | -0.15 -50.00% | -0.07 -27.27% |
| Revenue Q2Q % growth | 34.491M -3.40% | 38.288M 1.06% | 27.319M 10.58% | 35.249M 8.25% | 37.482M 8.67% | 41.41M 8.15% | 33.503M 22.64% | 38.426M 9.01% | 43.768M 16.77% | 46.515M 12.33% |
| EBITDA Q2Q % growth | 4.925M -24.03% | 10.037M -14.55% | -100.297K 98.18% | 5.758M 131.99% | 7.399M 50.23% | 10.413M 3.75% | 3.032M 3,123.03% | 7.072M 22.82% | 10.089M 36.36% | 11.278M 8.31% |
| EBIT Q2Q % growth | -344.077K -177.48% | 3.766M 30.45% | -6.65M 11.34% | -1.478M 4.95% | 687.143K 299.71% | 3.592M -4.62% | -3.886M 41.56% | -191.76K 87.03% | 2.451M 256.69% | 5.489M 52.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.25 -250.14% | -0.31 | 0.06 | 19.64% |
| Q1 2025 Q2Q % growth | -0.49 -84.77% | -0.47 | -0.02 | -3.31% |
| Q4 2024 Q2Q % growth | -0.17 80.90% | -0.12 | -0.05 | -38.89% |
| Q3 2024 Q2Q % growth | 72.18% | -0.06 | % | |
| Q2 2024 Q2Q % growth | 70.25% | -0.07 | % | |
| Q1 2024 Q2Q % growth | 17.13% | -0.27 | % | |
| Q4 2023 Q2Q % growth | -0.89 -8,800.00% | -0.38 | -0.51 | -132.68% |
| Q3 2023 Q2Q % growth | -0.22 -175.00% | -0.13 | -0.09 | -65.91% |
| Q2 2023 Q2Q % growth | -0.24 -580.00% | -0.04 | -0.20 | -488.24% |
| Q1 2023 Q2Q % growth | -0.32 -39.13% | -0.14 | -0.18 | -132.39% |
| Q4 2022 Q2Q % growth | -0.01 -114.29% | -0.01 | 0.00 | 26.45% |
| Q3 2022 Q2Q % growth | -0.08 11.11% | -0.01 | -0.07 | -1,468.63% |
| Q2 2022 Q2Q % growth | 0.05 150.00% | -0.04 | 0.09 | 222.55% |
| Q1 2022 Q2Q % growth | -0.23 -109.09% | -0.12 | -0.11 | -94.39% |
| Q4 2021 Q2Q % growth | 0.07 40.00% | -0.01 | 0.08 | 957.84% |
| Q3 2021 Q2Q % growth | -0.09 -325.00% | 0.02 | -0.11 | -467.65% |
| Q2 2021 Q2Q % growth | 0.02 112.50% | 0.01 | 0.01 | 96.08% |
| Q1 2021 Q2Q % growth | -0.11 31.25% | -0.11 | 0.00 | 1.96% |
| Q4 2020 Q2Q % growth | 0.05 600.00% | 0.03 | 0.02 | 78.25% |
| Q3 2020 Q2Q % growth | 0.04 | 0.03 | 0.01 | 56.86% |
| Q2 2020 Q2Q % growth | -0.16 | -0.06 | -0.10 | -161.44% |
| Q1 2020 Q2Q % growth | -0.16 -1,700.00% | -0.16 | 0.00 | -0.55% |
| Q4 2019 Q2Q % growth | -0.01 | -0.02 | 0.01 | 50.98% |
| Q3 2019 Q2Q % growth | 0.04 | 0.03 | 0.01 | 30.72% |
| Q2 2019 Q2Q % growth | 0.00 | -0.02 | 0.02 | 100.00% |
| Q1 2019 Q2Q % growth | 0.01 | 0.00 | 0.01 | 194.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 32.564M 8.01% | 30.342M | 2.222M | 7.32% |
| Q1 2025 Q2Q % growth | 24.705M 0.75% | 23.652M | 1.053M | 4.45% |
| Q4 2024 Q2Q % growth | 37.886M 20.10% | 35.715M | 2.171M | 6.08% |
| Q3 2024 Q2Q % growth | 35.704M 29.36% | 36.483M | -779K | -2.14% |
| Q2 2024 Q2Q % growth | 30.15M 343.38% | 30.359M | -209K | -0.69% |
| Q1 2024 Q2Q % growth | 24.522M -43.50% | 24.907M | -385K | -1.55% |
| Q4 2023 Q2Q % growth | 31.546M -33.73% | 29.604M | 1.942M | 6.56% |
| Q3 2023 Q2Q % growth | 27.6M -26.20% | 28.558M | -958K | -3.35% |
| Q2 2023 Q2Q % growth | 6.8M -38.74% | 47.539M | -40.739M | -85.70% |
| Q1 2023 Q2Q % growth | 43.4M 4.33% | 43.592M | -192K | -0.44% |
| Q4 2022 Q2Q % growth | 47.6M 6.01% | 46.46M | 1.14M | 2.45% |
| Q3 2022 Q2Q % growth | 37.4M -16.33% | 49.382M | -11.982M | -24.26% |
| Q2 2022 Q2Q % growth | 11.1M 120.67% | 43.794M | -32.694M | -74.65% |
| Q1 2022 Q2Q % growth | 41.6M -69.32% | 131.7M | -90.1M | -68.41% |
| Q4 2021 Q2Q % growth | 44.9M 116.37% | 127.07M | -82.17M | -64.67% |
| Q3 2021 Q2Q % growth | 44.7M -70.77% | 142.55M | -97.85M | -68.64% |
| Q2 2021 Q2Q % growth | -53.7M -137.66% | 136.93M | -190.63M | -139.22% |
| Q1 2021 Q2Q % growth | 135.6M -2.24% | 130.41M | 5.19M | 3.98% |
| Q4 2020 Q2Q % growth | -274.2M -280.04% | 159.21M | -433.41M | -272.23% |
| Q3 2020 Q2Q % growth | 152.9M -1.74% | 151.78M | 1.12M | 0.74% |
| Q2 2020 Q2Q % growth | 142.6M 14.45% | 145.39M | -2.79M | -1.92% |
| Q1 2020 Q2Q % growth | 138.7M 11.23% | 133.76M | 4.94M | 3.69% |
| Q4 2019 Q2Q % growth | 152.3M | 153.24M | -940K | -0.61% |
| Q3 2019 Q2Q % growth | 155.6M | 159.6M | -4M | -2.51% |
| Q2 2019 Q2Q % growth | 124.6M | 128.56M | -3.96M | -3.08% |
| Q1 2019 Q2Q % growth | 124.7M | 126.42M | -1.72M | -1.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.9% | -575% | 14.72% | 14.72% |
| Revenue | -2.66% | -17.29% | 0.01% | 0.01% |